Flecainide Acetate
Brand name: Flecainide Acetate
Rank #383 of 500 drugs by total cost
$25.1M
Total Cost
412,334
Total Claims
$25.1M
Total Cost
9,401
Prescribers
$61
Cost per Claim
97,693
Beneficiaries
941,929
30-Day Fills
$2,671
Avg Cost/Provider
44
Avg Claims/Provider
About Flecainide Acetate
Flecainide Acetate (sold as Flecainide Acetate) was prescribed 412,334 times by 9,401 Medicare Part D providers in 2023, costing the program $25.1M. At $61 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
| 386 | Nitrofurantoin Monohyd/M-Cryst (Nitrofurantoin Mono-Macro) | $24.4M | 1,173,249 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology